Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservation of fertility with GnRH agonist in premenopausal breast cancer patients receiving chemotherapy
2010-024503-27Phase 4Terminated
- Sponsor
- Noora Kaartinen
- Start
- Feb 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of leuprolide in breast cancer (2 arms), sponsored by Noora Kaartinen. Primary endpoint: Return of menstruation after chemotherapy. Started Feb 2011; status: terminated.
02
Drugs
leuprolide
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-024503-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024503-27.